Documents listed below are intended to inform Interested Parties in a timely manner about development at the European Medicines Agency, as part of the implementation of the new pharmaceutical legislation, of procedural or clarification documents/guidelines in relation to veterinary medicinal products. External consultation is expected to be held for each of the documents/guidelines listed. Unless otherwise specified, the consultation period for each document/guideline will be four weeks.
Please note that the current list of documents is not exhaustive and that titles of draft documents are for indication only, pending discussion within the CVMP during its meetings. The table will be updated to reflect changes as and when they occur.